Photo from Phuong Ly-Gallagher/LinkedIn
Jun 11, 2024, 05:36
Phuong Ly-Gallagher: What can be done NOW in the global space to advance care in colorectal cancer
Phuong Ly-Gallagher, Research Advocate Training and Support (RATS) Manager at
“’It is better represented in phase III studies but has almost negligible participation in other trial phases.’
As we approach Fight Colorectal Cancer’s next (virtual) Early Onset Think Tank, consider this in what can be done NOW in the global space to advance care in colorectal cancer.”
Quoting
“ASCO2024 LATAM Our analysis showed that the Latin American region is underrepresented in clinical trials. While 7.7% of all cancer cases in 2020 were diagnosed in LATAM, only 3.64% of oncology trials were conducted there. Scope for improvement!”
Read further.
Source: Phuong Ly-Gallagher/LinkedIn and Kamal S. Saini/LinkedIn
advancing cancer care
ASCO24
cancer
cancer diagnosis rates
Cancer research
clinical trial participation
clinical trial representation
colorectal cancer care
Early Onset Think Tank
Fight Colorectal Cancer
Fortrea Inc.
global oncology
Kamal S. Saini
Latin American region
LATM
OncoDaily
Oncology
oncology trial disparities
oncology trials
phase III studies
Phuong Ly-Gallagher
Research
Research Advocate Training and Support (RATS) Manager